Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Masato Nose"'
Autor:
Tomoko Ikeda, Hiroshi Fujii, Masato Nose, Yukiko Kamogawa, Tsuyoshi Shirai, Yuko Shirota, Tomonori Ishii, Hideo Harigae
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-14 (2017)
Abstract Background Bortezomib (Bz) is a proteasome inhibitor that directly targets antibody-producing plasma cells. We recently reported the first randomized control trial that evaluated the effects of Bz in patients with systemic lupus erythematosu
Externí odkaz:
https://doaj.org/article/efddea99a3c942279a83ea19151ef6b8
Autor:
Hiroshi Furukawa, Shomi Oka, Kota Shimada, Kiyoe Masuo, Fumiaki Nakajima, Shunichi Funano, Yuki Tanaka, Akiko Komiya, Naoshi Fukui, Tatsuya Sawasaki, Kenji Tadokoro, Masato Nose, Naoyuki Tsuchiya, Shigeto Tohma
Publikováno v:
Biomarker Insights, Vol 2015, Iss 10, Pp 63-73 (2015)
Externí odkaz:
https://doaj.org/article/a585a8d38854453dbdf1e2e8735fae46
Autor:
Hiroshi Furukawa, Shomi Oka, Kota Shimada, Kiyoe Masuo, Fumiaki Nakajima, Shunichi Funano, Yuki Tanaka, Akiko Komiya, Naoshi Fukui, Tatsuya Sawasaki, Kenji Tadokoro, Masato Nose, Naoyuki Tsuchiya, Shigeto Tohma
Publikováno v:
Biomarker Insights, Vol 10 (2015)
Interstitial lung disease (ILD) is frequently associated with collagen disease. It is then designated as collagen vascular disease-associated ILD (CVD-ILD), and influences patients’ prognosis. The prognosis of acute-onset diffuse ILD (AoDILD) occur
Externí odkaz:
https://doaj.org/article/aa75fba946124f3596106b1756ab4cb3
Autor:
Yukiko Kamogawa, Tomoko Ikeda, Tomonori Ishii, Tsuyoshi Shirai, Hiroshi Fujii, Yuko Shirota, Hideo Harigae, Masato Nose
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-14 (2017)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background Bortezomib (Bz) is a proteasome inhibitor that directly targets antibody-producing plasma cells. We recently reported the first randomized control trial that evaluated the effects of Bz in patients with systemic lupus erythematosus (SLE).
Autor:
Masanori Sugiyama, Masachika Fujiwara, Kimimasa Nakabayashi, Masato Nose, Ayumi Sumiishi, Hiroshi Kamma, Yasuo Ohkura, Ryota Matsuki
Publikováno v:
The Kitakanto Medical Journal. 65:61-68
Autor:
Yoshiaki Miura, Ken-ichi T. Suzuki, Eun-Young Kim, See-Wun Cho, Hisato Iwata, Tatsuhiko Miyazaki, Masato Nose
Publikováno v:
Archives of Toxicology. 89:2027-2038
The aryl hydrocarbon receptor (AHR) is responsible for susceptibility to its ligand-dependent responses. However, the effect of non-AHR factors is less clear. To explore the non-AHR factors, we used two mouse strains with different AHR genetic varian
Publikováno v:
Journal of Cancer Metastasis and Treatment. 4:56
Autor:
Tatsuhiko Miyazaki, Masashi Hirano, Midori Iida, Hoa Thanh Nguyen, Maria Claret Lauan Tsuchiya, Jean Yoo, Masato Nose, Tetsuro Agusa, Eun-Young Kim, Hisato Iwata
Publikováno v:
Archives of toxicology. 91(4)
Dioxins cause various toxic effects through the aryl hydrocarbon receptor (AHR) in vertebrates, with dramatic species and strain differences in susceptibility. Although inbred mouse strains C3H/HeJ-lpr/lpr (C3H/lpr) and MRL/MpJ-lpr/lpr (MRL/lpr) are
Autor:
Masato Nose
Publikováno v:
Inflammatory Diseases of Blood Vessels, Second Edition
Autor:
Tomohisa Sakaue, Yaeta Endo, Hidetaka Ohnuki, Shinji Fukuda, Eiji Nishiwaki, Hironao Nakayama, Masahiko Hatano, Hirofumi Inoue, Masato Nose, Takeshi Tokuhisa, Shigeki Higashiyama, Nobuaki Takemori, Daisuke Miwa
Publikováno v:
Blood. 119:2688-2698
Angiogenic homeostasis is maintained by a balance between vascular endothelial growth factor (VEGF) and Notch signaling in endothelial cells (ECs). We screened for molecules that might mediate the coupling of VEGF signal transduction with down-regula